Browse by UCL people
Group by: Type | Date
Number of items: 4.
Article
Cho, S;
Zammarchi, F;
Williams, DG;
Havenith, CE;
Monks, NR;
Tyrer, P;
d'Hooge, F;
... van Berkel, PH; + view all
(2018)
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-drug Conjugate Targeting PSMA, in Pre-clinical Models of Prostate Cancer.
Molecular Cancer Therapeutics
, 17
(10)
10.1158/1535-7163.MCT-17-0982.
|
|
Hartley, JA;
Flynn, MJ;
Bingham, JP;
Corbett, S;
Reinert, H;
Tiberghien, A;
Masterson, LA;
... Howard, PW; + view all
(2018)
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine.
Scientific Reports
, 8
, Article 10479. 10.1038/s41598-018-28533-4.
|
 |
|
Zammarchi, F;
Corbett, S;
Adams, L;
Tyrer, PC;
Kiakos, K;
Janghra, N;
Marafioti, T;
... van Berkel, PH; + view all
(2018)
ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies.
Blood
, 131
(10)
pp. 1094-1105.
10.1182/blood-2017-10-813493.
|
Thesis
|
Corbett, Simon Edward;
(2020)
Understanding the mechanisms of action of pyrrolobenzodiazepine dimer-based antibody-drug conjugates.
Doctoral thesis (Ph.D), UCL (University College London).
|
